Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Methotrexate
The First People's Hospital of Lianyungang
Knee Osteoarthritis
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Mindfulness meditation based on brain-computer interface
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Intracerebral Hemorrhage
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Mononuclear cells
Shandong Provincial Hospital
Chronic Atrophic Gastritis
1 trial -
Morphine
BRIGHT MINDS BIOSCIENCES INC.
Sleep Deprivation
1 trial -
Multiple-dose of Ciprofloxacin prophylaxis
The First People's Hospital of Lianyungang
Kidney Stones
1 trial -
NBP Softgel Capsules
The First People's Hospital of Lianyungang
Migraine
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Nitazoxanide Tablets
Vera Therapeutics
COVID-19
1 trial -
Nitroprusside Sodium
The First People's Hospital of Lianyungang
ST Segment Elevation Myocardial Infarction
1 trial -
Normal Saline (Placebo)
The First People's Hospital of Lianyungang
Disease of Respiratory System
1 trial -
Nutrient supplement to pregnant women (PNS)
United Therapeutics Europe Ltd
Stunting in Under-2 Children
1 trial -
Nutrition Intervention
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Nutritional Supplement
Aspire Biopharma Holdings
Healthy
1 trial -
Obinutuzumab
The First People's Hospital of Lianyungang
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial -
Oleoylethanolamide (OEA)
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Omeprazole
Hospital Authority, Hong Kong
Gastroesophageal Reflux Disease
1 trial -
Oral Chondroitin Sulfate (Flextrum)
COLLEGIUM PHARMACEUTICAL, INC
Meniscus Lesion
1 trial -
Oral Stimulant Drink
Cardiff Oncology
Volatile Organic Compounds
1 trial -
Oral carbohydrate (Outfast)
The First People's Hospital of Lianyungang
Gastrointestinal Surgery
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources